期刊文献+

唑来磷酸注射液加重肾脏损害1例 被引量:1

下载PDF
导出
摘要 1病例介绍 患者,女,62岁。因发热,全身酸痛,腰痛,乏力3 d于2012年7月12日就诊。患骨质疏松症2年余,4d前在外院静脉滴注唑来磷酸注射液(含唑来磷酸5 mg及注射用水,诺华制药有限公司生产,批号:SD293)100 mL。输液1 h (25滴·min-1),当时无不适。次日出现发热,体温38.6℃,2 d后热退,全身酸痛,腰痛,乏力;但无呼吸道症状,无尿频,尿急,尿痛,亦无尿量减少。既往患高血压病10余年,近2年服硝苯地平控释片30 mg, qd,发现尿微量清蛋白升高6个月余。既往无药物过敏史。诊断:高血压肾病。
出处 《医药导报》 CAS 北大核心 2014年第9期1255-1255,共1页 Herald of Medicine
  • 相关文献

参考文献3

二级参考文献15

  • 1孙瑞台.骨质疏松症的运动疗法应用及研究进展[J].国外医学(物理医学与康复学分册),1994,14(4):149-151. 被引量:11
  • 2申戈,宋三泰,江泽飞,卞寿庚,谢广茹,王雅杰,王杰军.唑来磷酸治疗恶性肿瘤引起高钙血症的临床研究[J].中华肿瘤杂志,2005,27(10):632-634. 被引量:18
  • 3马成青,张婕,尚玉芬.唑来膦酸治疗恶性肿瘤骨转移瘤疼痛的临床观察与护理[J].实用医技杂志,2006,13(23):4169-4170. 被引量:4
  • 4COMPSTON JE,SEEMAN E. Compliance with osteoporosis therapy is the weakest link[ J]. Lancet,2006,368(9540) :973 -974.
  • 5SIRIS ES, HARRIS ST, ROSEN CJ, et al. Adherence to bisphosphonate therapy and fracture rates in osteoporotic women : relationship to vertebral and nonvertebral fractures from 2 US claims databases[J]. Mayo Clin Proc,2006, 81 (8) :1013 - 1022.
  • 6BLACK DM,DELMAS PD,EASTELL R, et al. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis[ J]. N Engl Med,2007,356(18) :1809 - 1822.
  • 7LYLES KW, COLON-EMERIC CS, MAGAZINER JS,et al. Zoledronic acid and clinical fractures and mortality after hip fracture [J].N Engl J Med, 2007,357(18) :1799 - 1809.
  • 8DUNFORD JE, THOMPSON K, COXON FP,et al. Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates [ J ]. J Pharmacol Exp Ther, 2001,296 ( 2 ) : 235 - 242.
  • 9GREEN JR, MOLLER K, JAEGGI KA,et al. Preclinical pharmacology of CGP 42'446, a new, potent, heterocyclic bisphosphonate compound [ J ]. J Bone Miner Res, 1994,9 ( 5 ) :745 - 751.
  • 10DENNISON E, COOPER C. Epidemiology of osteoporotic fractures[ J]. Horm Res ,2000,54 (Suppl) 1:58 - 63.

共引文献26

同被引文献16

  • 1Werner M.Avoiding pitfalls in the diagnostics of bone neoplasms:importance of reference pathology[J]. Pathologe,2014,35 Suppl 2:242-248.doi:10.1007/s00292-014-2012-1.
  • 2McCoy TH Jr,Kim HJ,Cross MB,et al.Bone tumor recon- struction with the Ilizarov method[J].J Surg Oncol,2013,107(4):343-352.doi:10.1002/jso.23217.
  • 3Madu AJ,Ocheni S,Nwagha TA,et al.Multiple myeloma in Nigeria:an insight to the clinical,laboratory features,and outcomes[J].Niger J Clin Pract,2014,17(2):212-217.doi:10.4103/1119-3077.127561.
  • 4Schmidt KL,Vangsted AJ,Hansen B,et al.Synergy of two human endogenous retroviruses in multiple myeloma[J]. Leuk Res,2015,39(10):1125-1128.doi:10.1016/j.Ieu- kres.2015.06.014.
  • 5Steele T,Kolamunnage-Dona R,Downey C,et al.Assess- ment and clinical course of hypocalcemia in critical illness [J].Crit Care,2013,17(3):R106.doi:10.1186/ccl2756.
  • 6Cmilansky P,Mrozova L.Hypocalcemia-the most common complication after total thyroidectomy[J].Bratisl Lek Listy.2014,115(3):175-178.
  • 7Bove A,Di Renzo RM,Palone G,et al.Early biomarkers of hy- pocalcemia following total thyroidectomy[J].Int J Surg,2014,12 Suppl 1:S202-204.doi:10.1016/j.ijsu.2014.05.008.
  • 8张伟滨.骨转移性肿瘤的治疗策略[J].实用肿瘤杂志,2008,23(4):290-293. 被引量:19
  • 9张明帅,张国庆,欧江华,艾司克尔.阿尤甫,蒋威华,倪多.唑来磷酸联合卡培他滨治疗乳腺癌多发骨转移临床疗效研究[J].中国全科医学,2011,14(35):4103-4105. 被引量:7
  • 10黄越,孟晓岩.唑来磷酸治疗恶性肿瘤骨转移性疼痛的临床研究[J].实用药物与临床,2012,15(1):58-60. 被引量:13

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部